Moderna's COVID-19 vaccine generated a "strong immune response" among children between the ages of 6 and 11, the company has announced.
Moderna revealed the interim results from a trial consisting of 4,753 participants between the ages of 6 and 11, and it said the vaccine was well-tolerated and generated a strong immune response, CNN reports. "The majority of adverse events were mild or moderate in severity," the company said. In the trial, two doses were given to children 28 days apart. The children received smaller doses than adults.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
4 ways to give back this holiday seasonThe Explainer If your budget is feeling squeezed, remember that money is not the only way you can be generous around the holidays
-
4 tips for hosting an ecofriendly ThanksgivingThe Week Recommends Coming together for the holidays typically produces a ton of waste, but with proper preparation, you can have an environmentally friendly gathering.
-
Jussie Smollet conviction overturned on appealSpeed Read The Illinois Supreme Court overturned the actor's conviction on charges of staging a racist and homophobic attack against himself in 2019
-
ACA opens 2025 enrollment, enters 2024 raceSpeed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
-
McDonald's sued over E. coli linked to burgerSpeed Read The outbreak has sickened at least 49 people in 10 states and left one dead
-
Long Covid: study shows damage to brain's 'control centre'The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
-
Israel, UN agree to Gaza pauses for polio vaccinationsSpeed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
-
FDA OKs new Covid vaccine, available soonSpeed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
-
Mpox: how dangerous is new health emergency?Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
-
WHO declares mpox a global health emergencySpeed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
-
What is POTS and why is it more common now?The explainer The condition affecting young women
